"TH to issue results ... not sure if that is a good sign or a bad sign given it is an open label trial and results were touched on previously"
I know details aren't your strong point, but the primary endpoints for this trial are:
- Incidence of changes from baseline in haematology, biochemistry, and urinalysis parameters. [Time Frame: 24 weeks]
- Incidence and severity of treatment-emergent adverse events (TEAEs) [Time Frame: 24 weeks]
Results for these outcomes have not been released yet for any patients. So results have not been "touched on" previously.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.80M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 19.5¢ | 17.5¢ | $53.03K | 282.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 90934 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 282282 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
| CYP (ASX) Chart |